Program Launches, Earning Results, Upcoming Financial Releases, and Technical Updates - Research Reports on Express Scripts, Cigna, Health Net, WellCare and Molina

NEW YORK, July 29, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding Express Scripts Holding Company (NASDAQ: ESRX), Cigna Corp. (NYSE: CI), Health Net, Inc. (NYSE: HNT), WellCare Health Plans, Inc. (NYSE: WCG) and Molina Healthcare, Inc. (NYSE: MOH). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5206-100free.

--
Express Scripts Holding Company Research Reports
On July 24, 2014, Express Scripts Holding Company's (Express Scripts) stock rose 0.76% to end the day at $66.52 compared to the previous day's closing price of $66.02. The Company's stock increased 1.19% over the past three trading days compared to the Nasdaq Composite which rose 1.07% during the same trading period. The full research reports on Express Scripts are available to download free of charge at:

http://www.analystsreview.com/Jul-29-2014/ESRX/report.pdf

--
Cigna Corp. Research Reports
On July 17, 2014, Cigna Corp. (Cigna) reported that the Company and Harbin Clinic launched a collaborative care initiative that aims to improve patient access to health care, enhance care coordination, and achieve the goal of improved health, affordability and patient experience. Cigna stated that the initiative will benefit 5,300 individuals covered by a Cigna health plan who receive care from more than 220 health care professionals with Harbin Clinic. "We're thrilled to expand the collaborative care program in Georgia and look forward to working with Harbin Clinic to implement a health care model that rewards physicians for quality of care, rather than volume of services," said Robert Hamilton, M.D., Cigna's Regional Medical Executive for Georgia. "This new model will ultimately lead to a healthier population and lower medical costs, which is good for individuals, families, employers and doctors." The program became effective on July 1, 2014. The full research reports on Cigna are available to download free of charge at:

http://www.analystsreview.com/Jul-29-2014/CI/report.pdf

--
Health Net, Inc. Research Reports
On July 2, 2014, Health Net, Inc. (Health Net) announced that it will release its Q2 2014 financial results on August 6, 2014, Wednesday, before market opens. Following the earnings release, the Company will hold a conference call discussing its Q2 2014 financial results on the same day at 11:00 a.m. ET or 8:00 a.m. PT. A live webcast and replay of the conference call will be available at the Company's website. The full research reports on Health Net are available to download free of charge at:

http://www.analystsreview.com/Jul-29-2014/HNT/report.pdf

--
WellCare Health Plans, Inc. Research Reports
On July 24, 2014, WellCare Health Plans, Inc. (WellCare) reported its Q2 2014 financial results with GAAP net loss of $7.5 million, or $0.17 per diluted share compared to a GAAP net income of $46.9 million, or $1.07 per diluted share in Q2 2013. Dave Gallitano, WellCare's Chairman of the Board and CEO stated, "In assessing our results and outlook, we believe the focus should be on three issues. The first issue is the new population and utilization of services for the Florida Medicaid Managed Medical Assistance (MMA) program start-up. The second issue is claims reserve development and an increase in claims reserves to reflect our current estimate. The third issue is this quarter's impairment and other charges, primarily related to Easy Choice's continued poor performance." The Company now anticipates adjusted net income per diluted share for full year 2014 to be between $2.20 and $2.50, down from previous guidance of $4.40 to $4.75. The full research reports on WellCare are available to download free of charge at:

http://www.analystsreview.com/Jul-29-2014/WCG/report.pdf

--
Molina Healthcare, Inc. Research Reports
On July 24, 2014, Molina Healthcare, Inc.'s (Molina) stock remained unchanged at $46.23 compared to the previous day's closing price. The Company's stock gained 2.31% over the past five trading days compared to the Dow Jones Industrial Average which rose 0.62% and to the Standard & Poor's 500 which moved up 1.52% during the same trading period. The full research reports on Molina are available to download free of charge at:

http://www.analystsreview.com/Jul-29-2014/MOH/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

AnalystsReview.com

SOURCE Analysts Review